BBBY Bed Bath and Beyond Inc posts narrower Q4 2025 loss than estimates shares rise more than 7 percent Estrella Immunopharma ESLA Q1 loss deepens EPS miss of 906 percent rattles investor confidence Why Inspired Entertainment INSE deserves a spot on your radar now Breakdown Watch 20260508 RELX PLC RELX Stock Is It Accelerating Q2 2025 Profit Exceeds Views Market Wrap SP 500 slips slightly as major US indices finish in the red 2025 White House Correspondents Dinner Political and Media Sector Analysis Is Akari AKTX stock a favorable investment idea Weakens 20260420 US Warns Japan of Significant Delays in Tomahawk Missile Deliveries Due to Middle East Stockpiles Consumer Sentiment Drops to Record Low in May on Surging Gas Prices Amid Iran Conflict Nvidia Data Center Revenue Nearly Doubles as Strong Earnings Report Prompts Stock Decline Stock Market Futures Edge Higher as AI Momentum Boosts Tech Earnings Sentiment Marvell Technology Reports Fiscal First Quarter 2027 Results Retailers Navigate KShaped Economy with Dual Strategies of Price Cuts and Premium Offerings Sera Prognostics Q1 2026 Earnings EPS Matches Estimates Stock Surges 15 on Strategic Progress SoundThinking Inc SSTI Q1 2026 Earnings Significant EPS Miss Amidst Market Optimism CRGO Q4 2025 Earnings NarrowerthanExpected Loss Despite Macro Headwinds Galiano Gold GAU Q1 2026 Earnings EPS Falls Short of Estimates Yet Shares Climb WFC Q1 2026 Earnings EPS Beats Estimates by a Narrow Margin Stock Edges Higher ZIM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions Titan Machinery TITN Slips 109 as Shares Hover Near Key Support Nektar Therapeutics NKTR Slips 128 as Shares Approach Key Support Level SAB Biotherapeutics SABS Slides 381 as Biotech Sector Faces Headwinds Key Support Tested Sagimet Biosciences SGMT Inches Higher as Stock Tests Key Resistance at 748 Brookfield Property Partners 625 Preferred BPYPM Holds Steady at 1739 as Income Investors Eye Yield Zydus Lifesciences Revises Buyback Terms Higher Price Fewer Shares CNTX Q1 2026 Earnings Context Therapeutics Beats EPS Estimates with NarrowerThanExpected Loss Lucas GC Limited LGCL Nears Key Support After Modest Decline